TY - JOUR
T1 - Affairs of the Heart
T2 - Innovation in Cardiovascular Research and Development
AU - Honig, P.
AU - Terzic, A.
N1 - Publisher Copyright:
© 2017 ASCPT
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Cardiovascular disease represents the single largest contributor to morbidity and mortality, yet the flow of therapeutic innovation is lagging. Globally, academia, industry, and regulatory agencies must work together to address this gap, and ensure new disruptive therapeutic modalities to address growing needs of patients and society.
AB - Cardiovascular disease represents the single largest contributor to morbidity and mortality, yet the flow of therapeutic innovation is lagging. Globally, academia, industry, and regulatory agencies must work together to address this gap, and ensure new disruptive therapeutic modalities to address growing needs of patients and society.
UR - http://www.scopus.com/inward/record.url?scp=85024379270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85024379270&partnerID=8YFLogxK
U2 - 10.1002/cpt.737
DO - 10.1002/cpt.737
M3 - Editorial
C2 - 28718903
AN - SCOPUS:85024379270
SN - 0009-9236
VL - 102
SP - 162
EP - 168
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 2
ER -